Jung et al. indicated that a 3-aminoisobutyrate treatment in mice mitigates insulin resistance, inhibits inflammation, and promotes fatty acid oxidation via the AMP-activated protein kinase (AMPK)-peroxisome proliferator-activated receptor (PPAR)-delta [73]. Here, PPARA is linked to Insulin resistance.